Tigecycline: Difference between revisions

From IDWiki
(Created page with "* Glycylcycline antibiotic * Related to tetracycline and doxycycline, with expanded coverage to include streptococci, Enterobacteriaceae, and Acinetobacter...")
 
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Background==
* Glycylcycline antibiotic
* Related to [[tetracycline]] and [[doxycycline]], with expanded coverage to include [[streptococci]], [[Enterobacteriaceae]], and [[Acinetobacter]], but without coverage for unusual [[Gram-negative bacteria]] or [[Chlamydia trachomatis]]


*Glycylcycline antibiotic
[[Category:Glycyclcyclines]]

===Spectrum of Activity===

*Related to [[tetracycline]] and [[doxycycline]], with expanded coverage to include [[streptococci]] and [[Enterobacteriaceae]], but without coverage for unusual [[Gram-negative bacteria]] or [[Chlamydia trachomatis]]
*Does cover [[Acinetobacter]] and [[Stenotrophomonas]]

===Pharmacokinetics and Pharmacodynamics===

*Rapidly concentrates in tissue, but poor concentration in urine and lung tissue

==Dosing==

*'''Intraabdominal infection:''' 100 mg IV load followed by 50 mg IV q12h
*'''Pneumonia:''' 100 mg IV load followed by 50 mg IV q12h
**High dosing may be useful in HAP/VAP with 100 mg IV q12h
*'''Skin and soft tissue infection:''' 100 mg IV load followed by 50 mg IV q12h

==Safety==

*Black box warning for increased all-cause mortality (4 vs 3%), likely driven by standard dosing tigecycline in VAP
*Commonly causes nausea, vomiting, and diarrhea
*Also anemia, thrombocytopenia, hepatitis, jaundice, AKI

[[Category:Glycylcyclines]]

Latest revision as of 12:56, 26 April 2021

Background

  • Glycylcycline antibiotic

Spectrum of Activity

Pharmacokinetics and Pharmacodynamics

  • Rapidly concentrates in tissue, but poor concentration in urine and lung tissue

Dosing

  • Intraabdominal infection: 100 mg IV load followed by 50 mg IV q12h
  • Pneumonia: 100 mg IV load followed by 50 mg IV q12h
    • High dosing may be useful in HAP/VAP with 100 mg IV q12h
  • Skin and soft tissue infection: 100 mg IV load followed by 50 mg IV q12h

Safety

  • Black box warning for increased all-cause mortality (4 vs 3%), likely driven by standard dosing tigecycline in VAP
  • Commonly causes nausea, vomiting, and diarrhea
  • Also anemia, thrombocytopenia, hepatitis, jaundice, AKI